{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:08:06Z","timestamp":1759410486800},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002289","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T04:39:57Z","timestamp":1322887197000},"page":"e1002289","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modelling the Spread of HIV Immune Escape Mutants in a Vaccinated Population"],"prefix":"10.1371","volume":"7","author":[{"given":"Helen R.","family":"Fryer","sequence":"first","affiliation":[]},{"given":"Angela R.","family":"McLean","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.","volume":"191","author":"NM Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ni0304-233","article-title":"HIV vaccine design and the neutralizing antibody problem.","volume":"5","author":"DR Burton","year":"2004","journal-title":"Nat Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro1819","article-title":"The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.","volume":"6","author":"GB Karlsson Hedestam","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/JVI.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.","volume":"68","author":"P Borrow","year":"1994","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"RA Koup","year":"1994","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.","volume":"3","author":"P Borrow","year":"1997","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.94.5.1890","article-title":"Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.","volume":"94","author":"DA Price","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","article-title":"The influence of HLA genotype on AIDS.","volume":"54","author":"M Carrington","year":"2003","journal-title":"Annu Rev Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.290.5491.486","article-title":"Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.","volume":"290","author":"DH Barouch","year":"2000","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1128\/JVI.74.16.7485-7495.2000","article-title":"Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.","volume":"74","author":"MA Egan","year":"2000","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/JVI.74.6.2502-2509.2000","article-title":"Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.","volume":"74","author":"A Seth","year":"2000","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.","volume":"473","author":"SG Hansen","year":"2011","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0952-7915(98)80118-0","article-title":"Protective immunity induced by live attenuated simian immunodeficiency virus.","volume":"10","author":"RP Johnson","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/science.318.5847.28","article-title":"AIDS research. Promising AIDS vaccine's failure leaves field reeling.","volume":"318","author":"J Cohen","year":"2007","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/jiq152","article-title":"Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.","volume":"203","author":"PB Gilbert","year":"2011","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/354453a0","article-title":"Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.","volume":"354","author":"RE Phillips","year":"1991","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1128\/JVI.77.13.7367-7375.2003","article-title":"Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys.","volume":"77","author":"DH Barouch","year":"2003","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/415335a","article-title":"Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.","volume":"415","author":"DH Barouch","year":"2002","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/35085576","article-title":"Evolution and transmission of stable CTL escape mutations in HIV infection.","volume":"412","author":"PJ Goulder","year":"2001","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1128\/JVI.78.13.7069-7078.2004","article-title":"Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.","volume":"78","author":"TM Allen","year":"2004","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1001196","DOI":"10.1371\/journal.ppat.1001196","article-title":"Modelling the evolution and spread of HIV immune escape mutants.","volume":"6","author":"HR Fryer","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1069660","article-title":"Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.","volume":"296","author":"CB Moore","year":"2002","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1131528","article-title":"Founder effects in the assessment of HIV polymorphisms and HLA allele associations.","volume":"315","author":"T Bhattacharya","year":"2007","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/JVI.80.7.3617-3623.2006","article-title":"Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.","volume":"80","author":"J Martinez-Picado","year":"2006","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1128\/JVI.00465-07","article-title":"Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.","volume":"81","author":"H Crawford","year":"2007","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm992","article-title":"HIV evolution: CTL escape mutation and reversion after transmission.","volume":"10","author":"AJ Leslie","year":"2004","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/JVI.01231-06","article-title":"Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.","volume":"81","author":"B Li","year":"2007","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1515\/9781400841035","article-title":"Modeling Infectious Diseases in Humans and Animals","author":"MJ Keeling","year":"2008"},{"key":"ref30","article-title":"The HLA Factsbook","author":"SGE Marsh","year":"2000"},{"key":"ref31","article-title":"Global Immunization Data.","year":"2010"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"17441","DOI":"10.1073\/pnas.0708559104","article-title":"Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis.","volume":"104","author":"C Fraser","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1086\/425267","article-title":"Potential public health impact of imperfect HIV type 1 vaccines.","volume":"191","author":"R Anderson","year":"2005","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1473-3099(04)01148-X","article-title":"Could disease-modifying HIV vaccines cause population-level perversity?","volume":"4","author":"RJ Smith","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"ref36","article-title":"World Health Statistics 2010.","year":"2010"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00002030-200203080-00011","article-title":"HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?","volume":"16","author":"D Morgan","year":"2002","journal-title":"AIDS"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e32830bfed8","article-title":"Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.","volume":"22","author":"DM Butler","year":"2008","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/088922201750290023","article-title":"Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.","volume":"17","author":"US Fideli","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/oxfordjournals.aje.a009331","article-title":"Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group.","volume":"146","author":"EA Operskalski","year":"1997","journal-title":"Am J Epidemiol"},{"key":"ref41","first-page":"120","article-title":"Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner.","volume":"21","author":"MA Pedraza","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.","volume":"342","author":"TC Quinn","year":"2000","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.","volume":"272","author":"JW Mellors","year":"1996","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e5950","DOI":"10.1371\/journal.pone.0005950","article-title":"Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection\u2013a quantitative review.","volume":"4","author":"EL Korenromp","year":"2009","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00042560-199707010-00009","article-title":"Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group.","volume":"15","author":"EA Operskalski","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1086\/646609","article-title":"Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.","volume":"200","author":"JF Okulicz","year":"2009","journal-title":"J Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/605446","article-title":"Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.","volume":"200","author":"F Pereyra","year":"2009","journal-title":"J Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1128\/JVI.00580-08","article-title":"Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.","volume":"82","author":"PC Matthews","year":"2008","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1128\/JVI.02455-07","article-title":"HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.","volume":"82","author":"CM Rousseau","year":"2008","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1128\/JVI.00022-07","article-title":"Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.","volume":"81","author":"AJ Frater","year":"2007","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1128\/JVI.01041-08","article-title":"Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute\/early HIV-1 infection.","volume":"82","author":"ZL Brumme","year":"2008","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/00365541003621502","article-title":"Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients.","volume":"42","author":"F Caby","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/378301","article-title":"Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.","volume":"37","author":"AK Sethi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.","volume":"38","author":"JJ Parienti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1098\/rspb.2009.1232","article-title":"No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection.","volume":"276","author":"HR Fryer","year":"2009","journal-title":"Proc Biol Sci"},{"key":"ref57","article-title":"Mathematical epidemiology of infectious diseases: model building, analysis and interpretation","author":"O Diekmann","year":"2000"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e12303","DOI":"10.1371\/journal.pone.0012303","article-title":"Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.","volume":"5","author":"W Fischer","year":"2010","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.","volume":"105","author":"BF Keele","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/375606a0","article-title":"Antigenic oscillations and shifting immunodominance in HIV-1 infections.","volume":"375","author":"MA Nowak","year":"1995","journal-title":"Nature"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1371\/journal.pmed.0030403","article-title":"HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.","volume":"3","author":"M Altfeld","year":"2006","journal-title":"PLoS Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1098\/rspb.2009.2073","article-title":"How fast could HIV change gene frequencies in the human population?","volume":"277","author":"D Cromer","year":"2010","journal-title":"Proc Biol Sci"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T04:49:15Z","timestamp":1593319755000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002289"}},"subtitle":[],"editor":[{"given":"Rob J.","family":"De Boer","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,12,1]]},"references-count":62,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002289","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,1]]}}}